These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14940651)

  • 21. Hyaluronidase in the Urographic examination of children.
    GLADNIKOFF H; JACOBSSON E
    Acta Paediatr (Stockh); 1953 Sep; 42(5):393-7. PubMed ID: 13104145
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intramuscular blocked urography with hyaluronidase].
    TASCA M
    Arch Radiol; 1955; 30(3):512-7. PubMed ID: 13412333
    [No Abstract]   [Full Text] [Related]  

  • 23. [Further considerations on intramuscular urography with hyaluronidase; indications and limitations].
    SALVATI R
    Ann Radiol Diagn (Bologna); 1953; 26(2):153-60. PubMed ID: 13125187
    [No Abstract]   [Full Text] [Related]  

  • 24. Excretory urography in the young subject; hyaluronidase and tomography as aids.
    FAINSINGER MH
    S Afr Med J; 1950 Jun; 24(22):418-20. PubMed ID: 15431120
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the fibrinolytic effect of urine; inhibition of urinary fibrinolysis after subcutaneous injection of hyaluronidase].
    SEELICH F; PANTLITSCHKO M; KAISER E
    Enzymologia; 1953 Apr; 16(1):56-61. PubMed ID: 13068376
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of Intra-arterial and Subcutaneous Testicular Hyaluronidase Injection Treatments and the Vascular Complications of Hyaluronic Acid Filler.
    Wang M; Li W; Zhang Y; Tian W; Wang H
    Dermatol Surg; 2017 Feb; 43(2):246-254. PubMed ID: 27930375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronicase in intramuscular excretory urography.
    WARRES HL; KING AC
    Radiology; 1954 Nov; 63(5):730-3. PubMed ID: 13215803
    [No Abstract]   [Full Text] [Related]  

  • 28. SUBCUTANEOUS FLUID THERAPY.
    SMITH CR; HAMLIN RL; POWERS TE
    J Am Vet Med Assoc; 1965 May; 146():1045-8. PubMed ID: 14323732
    [No Abstract]   [Full Text] [Related]  

  • 29. [New treatment of paraphimosis with local subcutaneous hyaluronidase injections].
    BAVASTRELLI A
    Sicil Sanit; 1955 Feb; 8(2):99. PubMed ID: 13274143
    [No Abstract]   [Full Text] [Related]  

  • 30. Iodopyracet (diodrast) injection for orbital tumors.
    MANCHESTER PT; BONMATI J
    AMA Arch Ophthalmol; 1955 Oct; 54(4):591-5. PubMed ID: 13257990
    [No Abstract]   [Full Text] [Related]  

  • 31. Reactions following excretory pyelography in infants and children.
    DAVIS LA
    Radiology; 1958 Jul; 71(1):19-20. PubMed ID: 13568046
    [No Abstract]   [Full Text] [Related]  

  • 32. The histologic effects of four commonly used media for excretory urography and an attempt to modify the responses.
    McAlister WH; Palmer K
    Radiology; 1971 Jun; 99(3):511-6. PubMed ID: 5578696
    [No Abstract]   [Full Text] [Related]  

  • 33. [ON THE IMPROVEMENT OF THE RESULTS OF INTRAVENOUS PYELOGRAPHY].
    ZINNER G
    Fortschr Geb Rontgenstr Nuklearmed; 1963 Dec; 99():812-6. PubMed ID: 14121033
    [No Abstract]   [Full Text] [Related]  

  • 34. A MODIFIED TECHNIQUE FOR INTRAVENOUS PYELOGRAPHY.
    SERVADIO C
    Br J Urol; 1965 Aug; 37():385-9. PubMed ID: 14346443
    [No Abstract]   [Full Text] [Related]  

  • 35. [IMPROVEMENT OF THE RESULTS OF INTRAVENOUS UROGRAPHY BY RAPID INJECTION AND A NEW CONTRAST MEDIUM, 5-ACETYLAMINO-2,4,6-TRIIODOISOPHTHALAMIC ACID 3-METHYLAMIDE].
    MAURER HJ; TESKE HJ
    Arzneimittelforschung; 1964 Apr; 14():292-7. PubMed ID: 14238575
    [No Abstract]   [Full Text] [Related]  

  • 36. Routine high dose excretory urography.
    Gronner AT; Arkoff RS; Burhenne HJ
    Calif Med; 1967 Jul; 107(1):16-9. PubMed ID: 6045483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous urography in neonates and infants. What dose of contrast should be used?
    Cohen MD
    Br J Radiol; 1979 Dec; 52(624):942-4. PubMed ID: 526794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytodiagnosis of exudates; experiences with hyaluronidase supplements].
    HECKNER F; GOLTNER E
    Vox Sang; 1954 Nov; 3(4):1693-6. PubMed ID: 13220156
    [No Abstract]   [Full Text] [Related]  

  • 39. The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection.
    Kim HJ; Kwon SB; Whang KU; Lee JS; Park YL; Lee SY
    J Cosmet Laser Ther; 2018 Feb; 20(1):52-57. PubMed ID: 29199877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management.
    Kim DW; Yoon ES; Ji YH; Park SH; Lee BI; Dhong ES
    J Plast Reconstr Aesthet Surg; 2011 Dec; 64(12):1590-5. PubMed ID: 21807574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.